TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ardea Biosciences, Inc. (NASDAQ:RDEA) Investor Files Lawsuit Against Directors To Stop Block Merger With AstraZeneca

  • If you who purchased shares of Ardea Biosciences, Inc. (NASDAQ:RDEA) prior to April 23, 2012 and currently hold any of those NASDAQ:RDEA shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

April 25, 2012 (Shareholders Foundation) -- An investor in NASDAQ:RDEA shares filed a lawsuit against directors of Ardea Biosciences, Inc in effort to block the proposed takeover of Ardea Biosciences, Inc by AstraZeneca for $32 per share. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to Ardea Biosciences investors arising ou...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: